2020
DOI: 10.1080/14728222.2020.1841168
|View full text |Cite
|
Sign up to set email alerts
|

Tuft cells: an emerging therapeutic target for pancreatitis and pancreatic cancer?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…The identification of unique gene markers in tuft cells has enabled the exploration of their association with cancer [14]. For instance, DCLK1 has been found to be upregulated in renal clear cell cancer, pancreatic cancer, and colorectal cancer [68][69][70][71]. Moreover, KRAS mutant Dclk1 + cells can functionally contribute to the pathogenesis of pancreatic cancer and, therefore, are a potential target in cancer treatment [72].…”
Section: Tuft Cells In Intestinal Homeostasis and Cancermentioning
confidence: 99%
“…The identification of unique gene markers in tuft cells has enabled the exploration of their association with cancer [14]. For instance, DCLK1 has been found to be upregulated in renal clear cell cancer, pancreatic cancer, and colorectal cancer [68][69][70][71]. Moreover, KRAS mutant Dclk1 + cells can functionally contribute to the pathogenesis of pancreatic cancer and, therefore, are a potential target in cancer treatment [72].…”
Section: Tuft Cells In Intestinal Homeostasis and Cancermentioning
confidence: 99%